Terms: = Leukemia AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Diagnosis
88 results:
1. Plasma Cell leukemia with Successful Upfront Venetoclax in Combination with Allogeneic Transplantation.
Tang ASO; Ahmad Asnawi AW; Koh AZY; Chong SL; Liew PK; Selvaratnam V; Md Fauzi A; Lau NS; Tan SM
Am J Case Rep; 2023 Mar; 24():e938868. PubMed ID: 36882990
[TBL] [Abstract] [Full Text] [Related]
2. Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party.
Jung SH; Kim K; Yoon SE; Moon JH; Kim D; Kim HJ; Kim MK; Kim KH; Lee HJ; Lee JH; Kim SH; Yoo KH; Lee JH; Lee JJ
Blood Cancer J; 2022 Nov; 12(11):157. PubMed ID: 36404323
[TBL] [Abstract] [Full Text] [Related]
3. [PAX5-positive plasma cell leukemia presenting as lymphocytosis].
Tateno S; Hirao M; Kikuchi T; Tsukada Y; Kunieda H; Osada M; Yamazaki K; Denda R; Hirose S; Matsushita M; Ichikawa D; Hattori Y
Rinsho Ketsueki; 2022; 63(10):1415-1420. PubMed ID: 36351649
[TBL] [Abstract] [Full Text] [Related]
4. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell leukemia-Like Multiple Myeloma.
Jelinek T; Bezdekova R; Zihala D; Sevcikova T; Anilkumar Sithara A; Pospisilova L; Sevcikova S; Polackova P; Stork M; Knechtova Z; Venglar O; Kapustova V; Popkova T; Muronova L; Chyra Z; Hrdinka M; Simicek M; Garcés JJ; Puig N; Cedena MT; Jurczyszyn A; Castillo JJ; Penka M; Radocha J; Mateos MV; San-Miguel JF; Paiva B; Pour L; Rihova L; Hajek R
J Clin Oncol; 2023 Mar; 41(7):1383-1392. PubMed ID: 36315921
[TBL] [Abstract] [Full Text] [Related]
5. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
Fernández de Larrea C; Kyle R; Rosiñol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; Miguel JS; Bladé J; Rajkumar SV; Mateos MV
Blood Cancer J; 2021 Dec; 11(12):192. PubMed ID: 34857730
[TBL] [Abstract] [Full Text] [Related]
6. Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia.
Bezdekova R; Jelinek T; Kralova R; Stork M; Polackova P; Vsianska P; Brozova L; Jarkovsky J; Almasi M; Boichuk I; Knechtova Z; Penka M; Pour L; Sevcikova S; Hajek R; Rihova L
Br J Haematol; 2021 Oct; 195(1):95-107. PubMed ID: 34500493
[TBL] [Abstract] [Full Text] [Related]
7. A clinical perspective on plasma cell leukemia; current status and future directions.
Tuazon SA; Holmberg LA; Nadeem O; Richardson PG
Blood Cancer J; 2021 Feb; 11(2):23. PubMed ID: 33563906
[TBL] [Abstract] [Full Text] [Related]
8. Successful upfront cord blood transplantation for plasma cell leukemia in the first complete response after daratumumab therapy.
Ueno T; Sugio Y; Ohta T; Uehara Y; Ohno Y
Int J Hematol; 2021 Jun; 113(6):941-944. PubMed ID: 33483877
[TBL] [Abstract] [Full Text] [Related]
9. A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma.
Oliva S; De Paoli L; Ruggeri M; Caltagirone S; Troia R; Oddolo D; D'Agostino M; Gilestro M; Mina R; Saraci E; Margiotta Casaluci G; Genuardi E; Bringhen S; Boccadoro M; Omedé P
Ann Hematol; 2021 Feb; 100(2):437-443. PubMed ID: 33392702
[TBL] [Abstract] [Full Text] [Related]
10. Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell leukemia in the Era of Novel Agents.
Lemieux C; Johnston LJ; Lowsky R; Muffly LS; Craig JK; Shiraz P; Rezvani A; Frank MJ; Weng WK; Meyer E; Shizuru J; Arai S; Negrin R; Miklos DB; Sidana S
Biol Blood Marrow Transplant; 2020 Dec; 26(12):e328-e332. PubMed ID: 32961371
[TBL] [Abstract] [Full Text] [Related]
11.
Tuazon SA; Sandmaier BM; Gooley TA; Fisher DR; Holmberg LA; Becker PS; Lundberg SJ; Orozco JJ; Gopal AK; Till BG; Coffey DG; Nartea ME; Matesan MC; Pagel JM; Rajendran JG; Press OW; Bensinger WI; Green DJ
Bone Marrow Transplant; 2021 Jan; 56(1):202-209. PubMed ID: 32710011
[TBL] [Abstract] [Full Text] [Related]
12. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell leukemia: A Retrospective Cohort Study.
Wang H; Zhou H; Zhang Z; Geng C; Chen W
Turk J Haematol; 2020 May; 37(2):91-97. PubMed ID: 31769277
[TBL] [Abstract] [Full Text] [Related]
13. [A primitive plasma cell leukemia with immunoglobulin (Ig) E].
Rachidi M; Lazarian G; Letestu R; Lusina D; Desbene C; Vidal V; Eclache V; Baran-Marszak F; Cymbalista F; Fleury C
Ann Biol Clin (Paris); 2019 Oct; 77(5):557-561. PubMed ID: 31512579
[TBL] [Abstract] [Full Text] [Related]
14. Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell leukemia.
Tabchi S; Nair R; Kunacheewa C; Patel KK; Lee HC; Thomas SK; Amini B; Ahmed S; Mehta RS; Bashir Q; Qazilbash MH; Weber DM; Orlowski RZ; Alexanian R; Feng L; Manasanch EE
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):560-569. PubMed ID: 31201134
[TBL] [Abstract] [Full Text] [Related]
15. Plasma Cell Leukaemia: A Rare Yet Aggressive Plasma Cell Dyscrasia With A Very Poor Response To Conventional Therapy.
Khan N; Raza SS; Khan UI; Hafez I; Abdullah MA; Hassan M; Rukh Hijaz AS; Hussain AK; Nadeem MD
J Ayub Med Coll Abbottabad; 2019; 31(2):272-275. PubMed ID: 31094130
[TBL] [Abstract] [Full Text] [Related]
16. Oligosecretory Primary Plasma Cell leukemia with Atypical Morphological Abnormality.
Toriyama E; Imaizumi Y; Tsuruda K; Itonaga H; Sato S; Ando K; Sawayama Y; Hasegawa H; Hata T; Niino D; Yanagihara K; Miyazaki Y
Intern Med; 2019 Aug; 58(15):2213-2217. PubMed ID: 30996175
[TBL] [Abstract] [Full Text] [Related]
17. Epidemiology of Plasma Cell leukemia in the Czech Republic.
Zapletalova M; Krejci D; Jarkovský J; Muzik J; Dusek L; Pour L
Klin Onkol; 2019; 32(1):47-51. PubMed ID: 30764629
[TBL] [Abstract] [Full Text] [Related]
18. Plasma Cell leukemia: Definition, Presentation, and Treatment.
Gundesen MT; Lund T; Moeller HEH; Abildgaard N
Curr Oncol Rep; 2019 Jan; 21(1):8. PubMed ID: 30689121
[TBL] [Abstract] [Full Text] [Related]
19. Primary Plasma Cell Leukaemia: Case report and review of the literature.
Singh S; Rath A; Yadav S
Sultan Qaboos Univ Med J; 2018 Aug; 18(3):e397-e401. PubMed ID: 30607287
[TBL] [Abstract] [Full Text] [Related]
20. Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate.
Maral S; Bakanay SM; Yikilmaz AS; Dilek I
J Cancer Res Ther; 2018; 14(6):1431-1433. PubMed ID: 30488870
[TBL] [Abstract] [Full Text] [Related]
[Next]
